Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1989;14:629-635

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, X. P.
Right arrow Articles by Scicli, A. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, X. P.
Right arrow Articles by Scicli, A. G.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH

Hypertension, Vol 14, 629-635, Copyright © 1989 by American Heart Association


ARTICLES

Role of endogenous brain kinins in the cardiovascular response to intracerebroventricular melittin

XP Yang, OA Carretero, G Jacobsen and AG Scicli
Department of Medicine, Henry Ford Hospital, Detroit, Michigan 48202.

Intracerebroventricular infusion of the peptide melittin increases immunoreactive kinins in the cerebrospinal fluid of anesthetized dogs, probably secondary to activation of brain or cerebrospinal fluid kininogenases. Intracerebroventricular melittin also increases blood pressure and heart rate, possibly mediated by brain kinins, since intracerebroventricular bradykinin also increases blood pressure and heart rate. We tested whether the effects of centrally administered melittin on blood pressure and heart rate could be blocked by simultaneous infusion of a kinin receptor antagonist, [DArg0]Hyp3- Thi5,8[DPhe7]bradykinin, in normotensive awake rats. In the controls, intracerebroventricular infusion of kinin receptor antagonist given for 1 hour at a rate of 10 micrograms/hr blocked bradykinin-induced increases in blood pressure and heart rate by 80%. Basal blood pressure and heart rate were not affected by the kinin receptor antagonist alone. After a 30-minute infusion of melittin (8 micrograms/30 min), cerebrospinal fluid kininogenase activity (n = 17) rose from 0.13 +/- 0.05 to 0.43 +/- 0.1 ng/ml/min (p less than 0.02). Although cerebrospinal fluid kinins increased from below sensitivity (0.02 ng/ml, n = 12) to 0.19 +/- 0.1 ng/ml (n = 17), this change was due to drastic increases in three rats, whereas in 12 of them kinins were below sensitivity. Incubation of bradykinin (10 ng) with 0.1 ml rat cerebrospinal fluid for 5 minutes destroyed 70% of kinins, suggesting that rapid destruction may have made detection of increased CSF kinins difficult.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
Physiol. Rev.Home page
H. E. De Wardener
The Hypothalamus and Hypertension
Physiol Rev, October 1, 2001; 81(4): 1599 - 1658.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. Madeddu, P. P. Parpaglia, N. Glorioso, L. Chao, and J. Chao
Antisense Inhibition of the Brain Kallikrein-Kinin System
Hypertension, December 1, 1996; 28(6): 980 - 987.
[Abstract] [Full Text]


Home page
HypertensionHome page
I. M. Khan, D. H. Miller, J. Strickland, H. S. Margolius, and P. J. Privitera
Brain Kallikrein-Kinin System Abnormalities in Spontaneously Hypertensive Rats
Hypertension, April 1, 1995; 25(4): 524 - 530.
[Abstract] [Full Text]